100
Participants
Start Date
December 1, 2025
Primary Completion Date
February 28, 2034
Study Completion Date
February 28, 2034
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
The target patients are those who were attempted to implant the AC during the enrollment period of this surveillance. Patients will also be targeted even if all components of the TAMBE device (devices that can be used in combination with AC specified in IFU) were not used, or if a device other than the component of the TAMBE device was used.
CMIC Co, Ltd. Japan
INDUSTRY
W.L.Gore & Associates
INDUSTRY